6, 2022 /CNW/ - PanGenomic Health Inc. 17, 2023 /CNW/ - PanGenomic Health Inc. %. PanGenomic Health Inc. Robert Nygren, Executive Chair of PanGenomic Health The LOI contemplates that the Company will acquire all of Mindleap’s outstanding shares for a purchase price of C$4,000,000, payable by the issuance of units at an agreed-upon price of C$0. Get the latest Pangenomic Health Inc (NARA) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. com Joined January 2021. The Company's initial. F) stock quote, history, news and other vital information to help you with your stock trading and investing. Announces Director Resignations Jul. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth platform. David Coffman / George Duxberry. NARA | Komplette Pangenomic Health Registered (A) Aktien News ☑ Mit Realtime Kurs und Prognose der Pangenomic Health Registered (A) Aktie Analysiere mit wallstreetONLINE Pangenomic Health Registered (A) Aktie. . est une entreprise de santé de précision qui a développé une plateforme numérique d'auto-soins pour fournir des informations personnalisées et fondées sur des preuves sur les traitements naturels. (dba Bello Capital Partners) 310 Water Street, Suite 306. 38m; Incorporated 2015; Employees--Location Pangenomic Health Inc 102 3800 Wesbrook Mall VANCOUVER V6S 2L9 Canada CAN;. ftse-100PanGenomic Health Inc. 15. View daily, weekly or monthly format back to when Pangenomic Health Inc. Today's RangePanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Pangenomic Health-Aktie (NARA) Forum: Teilen Sie hier Ihre Meinungen und Trading-Ideen. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. 778 743 4642 778 743 4642. 0. Find companies based on country, sector, and other equity characteristics. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app as a resource to provide science. Jetzt entdecken Jetzt entdecken. Primary Industries. Ausländisches Symbol. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. . PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Our initial focus. @Fobibuddy The Company also announced that its board of directors has approved a reduction of the exercise price of an aggregate of outstanding 45,472,751 share purchase warrants of the Company (the “Warrants”) from $0. Notre objectif initial est la santé mentale. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Liste der 50 Aktien über einem Euro mit höchster Tagesperformance über alle Segmente. Pangenomic Health Inc. Aktueller Aktienwert heute inkl. 778 743 4642. Built as an extension to its Nara consumer app and website launched in 2022, the e-commerce platform on nara. Das Datum ist frei. (" PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its intention to apply for admission to trading on the Aquis Stock Exchange Growth Market ("AQSE") in the UK. 325. Listing and disclosure documents will be available at on the trading date. Log in to view data. (formerly named PlantGx Diagnostics Corp. CA2684692023. Compiled here, all relevant comments and discussions regarding the NARA Stock. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Nov. MICROSOFT AKTIE und aktueller Aktienkurs. 0 Euro pro Trade handeln (zzgl. What’s New. 9, 2023 /CNW/ - PanGenomic Health Inc. (NARA. Not for distribution to U. . (NARA. info@pangenomic. Artikel lesen 02. , 778 743 4642, info@pangenomic. zXx0qinflXRXXCMJ5PxV5vqU8IKF_XlXtuCcSomJ2yTFaVWPcMmvXlBVDQPanGenomic Health Inc (NARA) Message Board - Company Name: PanGenomic Health Inc, Stock Symbol: NARA, Industry: Medical - Healthcare - Total Posts: 13 - Last Post: 05/31/2023 08:25:13 AM - company/specific stock board. ISIN. Risikoanalyse zu PANGENOMIC HEALTH A anhand von objektiven Faktoren wie z. Lesen Sie Börsennachrichten und Hintergründe zum Aktienmarkt in Deutschland und der ganzen Welt. (MT Newswires) -- PanGenomic Health (NARA. Get the latest Pangenomic Health Inc (NARA) real-time quote, historical performance, charts, and other financial information to help you make more informed. Push Kurse werden börsentäglich von 8:00 bis 23:00 Uhr, samstags von 10:00 bis 13:00 Uhr und sonntags von 17:00 bis 19:00 Uhr aktualisiert. VANCOUVER, BC, Dec. 000 Aktien. PanGenomic Health Inc. Also Known As Zetta Capital Corp. Pangenomic Health Inc (LL30:MUN) set a new 52-week low during Thursday's trading session when it reached 0. 21. 778 743 4642. Nachrichten zur Aktie Pangenomic Health Inc Registered Shs -A- | A3DN26 |. ADRs) Liste der 50 Auslands-Aktien über einem Euro mit höchster Tagesperformance über alle Segmente. A3DN26. mit einem hohe Streubesitz von 87%. The Company’s initial focus is to support mental health. Finanzsoftware die Spaß macht - kostenlos und werbefrei. PanGenomic Health Inc. (“PanGenomic” or the “Company”) Admission to Trading on AQSE and First Day of Dealings. -0,87%. While a public benefit corporation is an enterprise created to generate social and public good, operating in a responsible and sustainable manner, it is allo. 57K. CI. Letzter Kurs 02. 22, 2022 /CNW/ - PanGenomic Health Inc. 778 743 4642 778 743 4642. We than track the effectiveness of the plant medicine by monitoring changes in a. Forum; Börsenspiel; ARIVA. 107,68. . President & CEO. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. Revenue in CAD (TTM) 0. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce that its Nara Plant Library is available now on the Nara app. , is pleased to announce the filing of its business acquisition report relating to its acquisition of all outstanding shares of Mindleap. . The Company's initial. ("IHI"), whereby PanGenomic Health will license IHI's CyberPatient AI medical education platform. 1 Year Return –81. MUJN Diagnostics Inc. from Mydecine Innovations Group Inc. PanGenomic Health Inc. In 2023 wurde bisher keine Dividende ausgeschüttet. ("PanGenomic" or the "Company") (CSE: NARA), is pleased to announce that, further to its news release dated September 1, 2022, it has entered into a. 15. Wertpapierdepots Musterdepots Watchlists Meine News Newsletter Forum Trading Desk Apps Social Media Podcasts Profil. Share your opinion and gain insight from other stock traders and investors. DTCFF. . Aktienverlauf & Wertentwicklung. “We are excited about. Jetzt im Neujahr sehe ich, dass dieser Verlust nicht mehr da ist. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. View daily, weekly or monthly format back to when Pangenomic Health Inc. company and executive profile by Barron's. 08 Mar, 2023, 07:30 ET. PanGenomic has developed a health-tech platform to provide further personal control over mental health treatments. (LL30. 30, 2023 /CNW/ - PanGenomic Health Inc. 011 expected by the market. Pangenomic Health competitive advantages and company strategy can generally be found in its financial reports archived here. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Joshua Bartch of Mydecine reports . 778 743 4642 info@pangenomic. Equities NARA CA69842E2050 Advanced Medical Equipment & Technology Delayed Canadian Securities Exchange. Es liegen keine Schätzungen zu dieser Aktie vor. Colin Quon. Find the latest Pangenomic Health Inc. Pangenomic Health Inc. On Thursday, Pangenomic Health Inc (LL30:BER) closed at 0. Analyst Potential (Euro) Potential Zeit; Aktuell sind keine Analysen verfügbar, die den gewählten Kriterien entsprechen. 12 April 2023 at 2:00 am · 8-min read. Pangenomic study might improve the completeness of human reference genome (GRCh38) and promote precision medicine. Es liegen keine Schätzungen zu dieser Aktie vor. Aktuelle Empfehlungen zur PANGENOMIC HEALTH Aktie. Nachrichten zur Aktie Taiwan Semiconductor Manufacturing Co. VANCOUVER, BC, Jan. Its products include a mobile app for consumers (Nara), a telehealth mental health app and telehealth. (“PanGenomic”) (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. 17 Following. 12, 2023 /CNW/ - PanGenomic Health Inc. Find the latest Pangenomic Health Inc. A copy of PanGenomic Health's financial statements for the year ended December 31, 2022 and the related Management's Discussion and Analysis is available on under PanGenomic Health's profile on. -0,87%. Wenn ein Anleger. CA24463V1013. Nachrichten zur PANGENOMIC HEALTH A Aktie - Aktuelle TOP-Meldungen - Die wichtigsten PANGENOMIC HEALTH A News im Überblick - seriös, schnell und kompetent. CA69842E2050. F) for CAD 4 million on August 31, 2022. Nachrichten zur Aktie Microsoft Corp. kündigt Rücktritt von Direktoren an 13. der ISIN CA69842E2050 . B. Finanzsoftware die Spaß macht - kostenlos und werbefrei. View daily, weekly or monthly format back to when Pangenomic Health Inc. Pangenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Ich möchte hier die Diskussion zur Aktie PanGenomic Health Solutions | PanGenomic eröffnen, um einen regen Austausch über die sich ergebenden Chancen zu führen. NARA Date: December 23, 2022 Is this an updating or amending Notice: Yes No If yes provide date(s) of prior Notices: Issued and Outstanding Securities of Issuer Prior to Issuance: 93,040,972 Pricing Date of news release announcing proposed issuance: N/A orPanGenomic Health Aktie, WKN: A3DN26, ISIN: CA69842E2050 Aktueller Aktienkurs, Charts, News, Stammdaten anzeigen In Ihrem Browser ist JavaScript deaktiviert. View the latest PanGenomic Health Inc. PanGenomic Health Inc. Weltweit vertrauen Kunden der DWS als Anbieter für integrierte Anlagelösungen. Aktienchart mit vielen Chartindikatoren & Vergleichsmöglichkeiten inkl. Here, we use an automated pipeline of human pangenomic analysis to build gastric. 31 Jan, 2023, 07:30 ET. $512. PanGenomic Health Inc is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support mental health. Pangenomic Health Inc. Revenue in CAD (TTM) 0. 2. Artikel lesen 02. For more information, please contact: Jerry Lai, Investor Relations Maryam Marissen, President & CEO. com. Nachrichten zur Aktie Defence Therapeutics Inc Registered Shs -A- Reg S. Pangenomic Health Inc. 0. PanGenomic Health Inc. Artikel lesen 01. Apr. Shares Outstanding 71. VANCOUVER, BC, May 2, 2023 /CNW/ - PanGenomic Health Inc. Find the latest Pangenomic Health Inc. VANCOUVER, BC, March 2, 2023 /CNW/ - PanGenomic Health Inc. PanGenomic Health Inc. Das Datum ist frei. Apr. Zu den erfolgreicheren Aktien des Tages zählt am Montagvormittag der Anteilsschein von Pangenomic Health A. PanGenomic Health interim loss widens amid higher costs Aug. PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce the results of its Annual. Forum; Kann das was ? Kann das was ?. The Quality Forum provides. com is subject to the. 20 per Share. 21, 2022 /CNW/ - PanGenomic Health Inc. ("PanGenomic Health" or the "Company") (CSE: NARA) is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. PanGenomic is committed to helping more people discover plant-based health remedies and giving them greater personal control over. In the fields of molecular biology and genetics, a pan-genome ( pangenome or supragenome) is the entire set of genes from all strains within a clade. Likes. Letzte Dividende. ("PanGenomic" or the "Company") (CSE: NARA) (AQSE:NARA) is pleased to announce that, further to its news release dated 9 August 2023, the Company intends to complete the shares-for-debt transaction (the "Debt Settlement Transaction") with certain creditors of the Company, pursuant to which the Company will settle $281,964. ISIN. See other industries within the Information sector: All Other Telecommunications , Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services , Media Streaming Distribution Services, Social Networks, and Other Media Networks and Content Providers , Motion Picture and Video Industries , Newspaper, Periodical, Book,. 1 M. PanGenomic Health Retains Social Media and Data Intelligence Advisory Firm and Announces Shares for Debt Settlement. PanGenomic Health Inc. by Globe Newswire January 30, 2023. Ins Portfolio Zur Watchlist. PANGENOMIC HEALTH A Fundamentalanalyse - hier erhalten Sie eine Analyse der PANGENOMIC HEALTH A Aktie nach fundamentalen Kennzahlen wie KGV, relative Performance, Mittelfrist-Trend usw. 30. January 09, 2023 at 07:30 am. The Company released a new version of its. Pangenomic Health also announces that its Nara app now also. ("PanGenomic") (CSE: NARA) is pleased to announce that it has engaged Meus Management Inc. 57. Company Profile. Ausländisches Symbol. Heute vor 5 Jahren fand an der Börse NYSE wochenend-bedingt kein Handel mit der CVS Health-Aktie statt. Übersicht Deine Holdings (0) Dividenden AnalysenFor several years, I’ve been working to change the world of healthcare by leveraging the power of tech, an effort that has landed me on the diverse and passionate team behind PanGenomic Health. /CNW/ - PanGenomic Health Inc. Pangenomic Health will provide further updates on its application to list on the AQSE when available. 0,024. Built as an extension to its Nara consumer app and website launched in 2022, the e-commerce. 778 743 4642. PanGenomic Health Corp. Using proprietary algorithms, the PlantGx platform translates health data into concise. Zeit. VANCOUVER, BC, Jan. PANGENOMIC HEALTH A AKTIE und aktueller Aktienkurs. The Company's initial. PanGenomic Health Subsidiary Signs Non-Binding MoU with Psy Integrated Health for Diagnostic Testing Joint Venture. Earnings vs Industry: NARA is unprofitable, making it difficult to compare its past year. ("PanGenomic" or the "Company") (CSE: NARA) today issued a letter to shareholders from its executive team. 11. 58,940. -4,11 %. CEOPanGenomic Health share price and NARA stock charts. PanGenomic Health Inc. PanGenomic Health Inc. 1 Year Return –84. Historical performance for Pangenomic Health Inc. ADRs) Westag & Getalit AG (Vz. ("PlantGx"), has signed a development partnership. Employees. The MUJN clinical decision support platform provides health practitioners with access to the consumer's mobile app data and their diagnostic reports. is a precision health company that has developed a self-care digital platform to deliver personalized, evidence. PanGenomic Health Inc - PanGenomic Health Subsidiary Announces First Sale of BDNF Biomarker Tests PR Newswire LONDON, United Kingdom, November 17 17 November 2023 PanGenomic. While a public benefit corporation is an enterprise created to generate social and public good, operating in a responsible and sustainable manner, it is allowed to make a profit. 0214, 6. 30 per Class A Common Share of the Company (a “Share”) to $0. is pleased to announce that its subsidiary, PlantGx Diagnostics Corp. helloitsasos , 11/18/2022. PANGENOMIC HEALTH A Rating: Hier finden Sie Rating-Informationen zu PANGENOMIC HEALTH A und Ratings der PANGENOMIC HEALTH A Anleihen sowie der Peer Group. 0201, set on Aug 23, 2023. PanGenomic Health Inc. PANGENOMIC HEALTH A Schätzungen: Hier finden Sie einen Überblick über die erwartete Entwicklung der wichtigsten Kennzahlen. 2021 habe ich mit Aktien Verlust gemacht (ca. PanGenomic Health Inc. CN) stock quote, history, news and. The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings. Fobi Announces The Commercial Launch Of PulseIR With First Client, Digital Health Platform PanGenomic Health Inc. PanGenomic Health Inc. 2 Ratings. About PanGenomic Health. Entdecken Sie die Märkte heute mit TradingView. En tant qu'entreprise de bienfaisance. In addition, PanGenomic has engaged Generation IACP Inc. 2 days ago · Vancouver, Kelowna and Delta, British Columbia--(Newsfile Corp. Over this period, the share price is down -91. PanGenomic Health Completes Acquisition of Mindleap Health. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 ("LOI") with Interactive Health Inc. 31, 2023 /CNW/ - PanGenomic Health Inc. MUJN has also completed its first sale of the point-of-care test to health clinics in Canada. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. ADRs) Commerzbank AG (spons. PanGenomic Health Inc. PANGENOMIC HEALTH A Rating: Hier finden Sie Rating-Informationen zu PANGENOMIC HEALTH A und Ratings der PANGENOMIC HEALTH A Anleihen sowie. Jetzt entdecken Jetzt entdecken. has signed an letter of intent (LOI) for the sale of its digital technology subsidiary, Mindleap Health Inc. com. View LL30 revenue estimates and earnings estimates, as well as in-depth analyst breakdowns. Der Schlusskurs der Aktie betrug am vorangegangen Handelstag 75,18 USD. A publicly-traded benefit corporation (CSE:NARA). . Ausländisches Symbol. Pangenomic Health Inc (LL30:BER) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more. On Tuesday, Pangenomic Health Inc (LL30:FRA) closed at 0. $1. Operating Status Active. (" PanGenomic " or the " Company ") (AQSE:NARA) (CSE:NARA), a precision health company that has developed a self-care digital platform to deliver. 12, 2023 /CNW/ - PanGenomic Health Inc. Pangenomic Health Inc. 30: AN Pangenomic Health Inc. Interaktiver realtime Chart zur PanGenomic Health Aktie. It develops a self-care digital platform to deliver personalized, evidence-based information about natural treatments to support. Novum Securities Limited, AQSE corporate Advisor. 1 Mydecine news release. Quotes Pangenomic Health Inc. View real. Vincent Lum CEO and Director at Pangenomic Health- Helping individuals take control of their health by providing personalized information (based on your needs, and biomarkes) on the use of plant. PanGenomic Health is UK's first listed Public Benefit Corp after Aquis IPO. Discover historical prices for NARA. It provides independent reviews of certain decisions. Class A reported ― EPS in relation to -C$0. Public asset : 143,838 USD. 25 Tage Jubiläumsparty: Jetzt mitmachen und täglich neue Gewinnchance sichern. S. 20 per Unit, or such higher price as the Canadian Securities Exchange may require. About PanGenomic Health Inc. Love this for my natural remedy guide I never know what I should get or how to use it and Nara does that all for me perfectly. CN) stock quote, history, news and other vital. Nara is a mental health app that curates natural remedies for individuals to manage and improve their mental wellness. A3DN26. Pangenomic uses your genome/ proteomic profile to help users select the best plant medicine for their specific needs. VANCOUVER, BC, Jan. in funding over 1 round. See the company profile for Pangenomic Health Inc. PanGenomic Health’s Tweets. Stock analysis for PanGenomic Health Inc (LL30:Frankfurt) including stock price, stock chart, company news, key statistics, fundamentals and company profile. 0500. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Pangenomic Health Inc. PanGenomic will launch the PlantGx platform in Canada and the United States in the summer 2022. S&P 500. The Company, through its subsidiaries, is engaged in developing a self-care digital platform to deliver personalized, evidence-based information about natural treatments. Ein Nutzer diskutiert die Aktie von Pangenomic Health Inc. 58,940. CNW Group. ("MUJN Diagnostics"), has signed a master services agreement with Hemex Health Inc. 09 Feb, 2023, 07:30 ET. Catalog; For You; Stockwatch Daily. Own your health journey. Die Pangenomic Healt a-Aktien notieren unter der WKN bzw. The. reported earnings results for the third quarter and nine months ended September 30, 2022. 11. 0500. Pangenomic Health Inc. Founded Date 2015. com Bello Holdings Inc. ("PanGenomic Health" or the "Company") (CSE: NARA), is pleased to announce its subsidiary, MUJN Diagnostics Inc. PANGENOMIC HEALTH A AKTIE Termine - hier erhalten Sie eine Übersicht über alle anstehenden und vergangenen Termine wie Quartalszahlen und Hauptversammlung von PANGENOMIC HEALTH A AKTIE. ("PanGenomic" or the "Company") (CSE: NARA) today issued a letter to shareholders from its executive team. Maryam Marissen President & CEO PanGenomic Health Inc. EUR. Novum Securities Limited, AQSE corporate Advisor. ca - Fri Apr 21, 4:30PM CDT. The PanGenomic personalized health platform helps consumers and healthcare practitioners connect with precision plant-based mental health treatments. Automatisch Scrollen. Registered as a British Columbia benefit company, PanGenomic Health's mission is to promote and improve. Robert Nygren. PanGenomic Health Inc. (“MUJN Diagnostics”), has launched its BDNF (brain-derived neurotrophic factor) mental health biomarker health assessment service and. Maryam Marissen. PanGenomic Health is a. Our initial focus is on mental health. PanGenomic Health Inc. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. View the latest PanGenomic Health Inc. PanGenomic Health. Top 50 Performer Ausland. All content on FT. is a precision health company. Aktueller PANGENOMIC HEALTH Aktienkurs (WKN: A3DN26 | ISIN: CA69842E2050) in Realtime, Charts und wichtige Angaben wie News, Umsätze, Analysen, Kennzahlen,. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. is a public benefit company. (the "Company" or "PanGenomic Health") is pleased to announce that its shareholders have approved the sale of. ±0. The Company's initial. Nachrichten zur Aktie Pangenomic Health Inc Registered Shs -A- | A3DN26 | CA69842E2050. Official Data Partner. View real. PANGENOMIC HEALTH A Aktie Orderbuch Xetra - Bid-Ask Volumen mit aktuellen Kursen - Times & Sales zu A3DN26 - CA69842E2050 - Realtimekurse VANCOUVER, BC, June 6, 2023 /CNW/ - PanGenomic Health Inc. PanGenomic Health Aktie: Aktueller Aktienkurs Charts Nachrichten Realtime WKN: A3DN26 | ISIN: CA69842E2050NARA. PanGenomic Health Inc. Volkswagen (VW) vz. ("PanGenomic Health" or the "Company") (CSE: NARA) (AQSE: NARA), announced today that independent directors, Peter Green and Jonathan. 0,0224. The Company's initial focus is to support mental health. ROIC % explanation, calculation, historical data and morePangenomic Health Inc Aktie - Aktuelle Kurse und Unternehmensdaten. (“IHI”), whereby PanGenomic Health will license IHI’s. PanGenomic Health Admitted to Trading on the AQSE Growth Market in London,. Anzeige. Pangenomic Health Inc. 13 PANGENOMIC HEALTH INC REGISTERED SHS -A- Börsenplätze - hier finden Sie die aktuellen Preise der PANGENOMIC HEALTH INC REGISTERED SHS -A- Aktie an allen deutschen und ausländischen Börsenplätzen. (“PanGenomic Health” or the “Company”) (CSE: NARA) (AQSE: NARA), is pleased to announce that it has entered into a non-binding letter of intent dated May 26, 2023 (“LOI”) with Interactive Health Inc. Investor Help Forum;06 Sep, 2022, 19:17 ET. Kurs. The two companies are jointly developing targeted biomarker diagnostics to help patients undergoing. PanGenomic Health is a precision health company that has developed a self-care digital platform to deliver personalized, evidence-based information about natural treatments. PanGenomic Health Inc. Shares Outstanding 71. euro stoxx 50.